Acetylcholinesterase Inhibitors (Donepezil, Rivastigmine, Galantamine) Preserve Synaptic Acetylcholine, They Do NOT Supply Choline (Boundary Pedagogical Card)

Standard acetylcholinesterase-inhibitor medications for Alzheimer disease preserve synaptic acetylcholine; they do not supply choline or alter phosphatidylcholine metabolism. Confusing these mechanisms leads to incorrect inferences about both dietary choline and prescription Alzh

Type

evidence-claim

Domain

h10_altered_intercellular_communication

Grade

A

License

CC BY-NC 4.0

card_id

L-021b

hallmarks

h10_altered_intercellular_communication

cluster

boundary_pedagogical

primary_disease_area

alzheimers

evidence_tier

A

evidence_anchor_count

4

intake_round

R23

intake_date

2026-05-26

related_experts

related_biomarkers

related_interventions

related_trials

collection_pages

/research/boundary-pedagogical/achei-vs-choline,/research/interventions/cholinesterase-inhibitors

LongProof Longevity Dynamic · LIGHT HOPE / x1000.ai · longevity.x1000.ai · 2026 · source

Read-only aggregated view. Longevity Evidence is the source of record; this catalog shows provenance as-is — no ratings, no reviews.